Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fimasartan/Hydrochlorothiazide in Essential Hypertension
NCT01258673Phase 3Completed
- Sponsor
- Boryung
- Start
- Nov 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fimasartan in essential hypertension, sponsored by Boryung. Started Nov 2010; status: completed.
02
Drugs
fimasartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01258673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01258673.